← Back to search
CCS ASSOCIATES, INC.
MCLEAN, VA, 22102
UnclaimedClaim this profile (free)
Small Business
Prime contracting experience
14 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | REGULATORY PREPARATION, REVIEW, AND SUBMISSION FOR CLINICAL TRIALS ASSOCIATED WITH NIDA DRUG SUPPLY PROGRAM. N01DA-23-8933. MARCH 27, 2026 TO MARCH 26, 2027 | 75N95023D00025USAspending | $335,910 | Aug 18, 2026 | Mar 27, 2026 – Mar 26, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | THE PURPOSE OF THE ACQUISITION IS TO PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS NECESSARY TO SUPPORT THE IDENTIFICATION, DEVELOPMENT, AND QUALIFICATION OF POTENTIAL CANCER PREVENTIVE AGENTS FOR INVESTIGATIONAL NE | — | $6,154,941 | Aug 12, 2026 | Sep 30, 2023 – Sep 29, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) AT THE NATIONAL CANCER INSTITUTE (NCI). NCI AND DCP HAVE A RECURRING REQUIREMENT FOR REGULATORY SERVICES AND TECHNICAL | — | $12,412,251 | Aug 3, 2026 | Sep 30, 2023 – Sep 29, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF REGULATORY SUPPORT FOR CANCER PREVENTION AGENT DEVELOPMENT | — | $13,247,902 | Jun 11, 2026 | Sep 30, 2018 – Sep 29, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF TECHNICAL INFORMATION RESEARCH RESOURCES FOR CANCER PREVENTIVE AGENT DEVELOPMENT | — | $11,379,713 | Jun 11, 2026 | Sep 30, 2018 – Sep 29, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | REGULATORY AFFAIRS SUPPORT. CCS ASSOCIATES, INC. N01DA-23-8933. APRIL 1, 2024 TO MARCH 31, 2025 | 75N95023D00025USAspending | $307,737 | May 28, 2026 | Apr 1, 2024 – Mar 31, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | REGULATORY PREPARATION, REVIEW, AND SUBMISSION FOR CLINICAL TRIALS ASSOCIATED WITH NIDA DRUG SUPPLY PROGRAM. N01DA-23-8933. APRIL 1, 2025 TO MARCH 31, 2026 | 75N95023D00025USAspending | $394,539 | Dec 23, 2025 | Apr 1, 2025 – Mar 31, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES | — | $294,194 | Sep 5, 2025 | Sep 14, 2023 – Sep 13, 2026 |
| Prime | Department of Health and Human Services Food and Drug Administration | THE CONTRACTOR SHALL PROVIDE THE FOLLOWING TASKS/DELIVERABLES OVER THE COURSE OF THE CONTRACT. | — | $1,172,493 | Jul 15, 2025 | Sep 2, 2021 – Sep 29, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF : REGULATORY AFFAIRS SUPPORT. SEPTEMBER 22, 2017 - SEPTEMBER 21, 2022. N01DA-17-8933. | — | $273,577 | Jan 2, 2025 | Sep 22, 2017 – Sep 19, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF, R&D - VASCULAR INTERVENTION/INNOVATIONS THERAPEUTIC ADVANCES | — | $2,471,798 | Sep 26, 2024 | Nov 15, 2013 – Sep 14, 2020 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF CCS ASSOCIATES INC:1109683 [16-065720] | HHSN261201100016IUSAspending | $1,286,665 | Mar 31, 2023 | Sep 15, 2016 – Sep 14, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | CCS ASSOCIATES, INC. REGULATORY SUPPORT FOR CANCER PREVENTION AGENT DEVELOPMENT | — | $14,612,856 | Jan 13, 2022 | Sep 30, 2011 – Sep 29, 2018 |
| Prime | Department of Health and Human Services National Institutes of Health | TECHNICAL INFORMATION RESEARCH RESOURCES FOR CANCER PREVENTIVE AGENT DEVELOPMENT | — | $13,264,779 | Jan 13, 2022 | Sep 30, 2011 – Sep 29, 2018 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
1 record from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | HOPO COHORT 7 - REGULATORY SUPPORT PO89141 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: DECORPORATION MCM PHASE 1 CLINICAL SAFETY STUDY View parent award on USAspending | 75N93020D00011USAspending | $412,236 | Dec 20, 2023 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.